Clinical trial · Interventional
High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer
High-Flow Oxygen for Exertional Dyspnea in Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This randomized phase II trial studies how well high-flow oxygen works in reducing difficulty breathing during exercise (exertional dyspnea) in patients with cancer. Dyspnea is linked to decreased lung function, quality of life, and survival. High-flow oxygen is a device that delivers heated and humidified oxygen through the nose. This may be effective in reducing dyspnea, and may help patients' lungs function better and improve their quality of life.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Dyspnea | — | UNRESOLVED | — |
| Malignant Neoplasm | Malignant Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Oxygen Therapy | Procedure | — | UNRESOLVED |
| Quality-of-Life Assessment | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
| Respiratory Therapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- Arm I (high-flow oxygen)
- description
- Patients receive high-flow oxygen via nasal prongs during a structured stationary bicycle exercise session.
- interventionNames
- Procedure: Oxygen Therapy
- Other: Quality-of-Life Assessment
- Other: Questionnaire Administration
- type
- EXPERIMENTAL
- label
- Arm II (high-flow air)
- description
- Patients receive high-flow air via nasal prongs during a structured stationary bicycle exercise session
- interventionNames
- Procedure: Oxygen Therapy
- Other: Quality-of-Life Assessment
- Other: Questionnaire Administration
- type
- ACTIVE_COMPARATOR
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of cancer, with evidence of primary or secondary lung involvement * Average dyspnea Borg Scale \>= 4 of 10 with severe exertion over the past week * Oxygen saturation \> 90% on ambient air at time of assessment * Able to communicate in English or Spanish * Karnofsky performance status \>= 50% * Seen at Supportive Care, cardiopulmonary center, thoracic radiation oncology or thoracic medical oncology Exclusion Criteria: * Resting dyspnea modified Borg Scale \> 7 of 10 at enrollment * Severe obstructive lung disease (forced expiratory volume in 1 second \[FEV1\]/forced vital capacity \[FVC\] \< 70% post bronchodilator and forced expiratory volume in 1 second \< 30% predicted) * Delirium (i.e., Memorial Delirium Rating Scale \> 13) * History of unstable angina or myocardial infarction in the last week * Acute pulmonary embolus or pulmonary infarction in the last week * Thrombosis of lower extremities in the last week * Acute myocarditis, pericarditis, or endocarditis in the last week * Symptomatic aortic stenosis or syncope in the last week * Suspected dissecting aneurysm * Severe untreated resting arterial hypertension (\> 200 mmHg systolic, \> 120 mmHg diastolic) at the time of enrollment * Uncontrolled arrhythmias causing symptoms or hemodynamic compromise in the last week * Uncontrolled heart failure in the last week * Pleural effusion requiring thoracentesis within 1 week of study enrollment or scheduled during the study period * Airway obstruction requiring stenting within 1 week of study enrollment or scheduled during the study period * Pneumonia requiring antibiotics at the time of study enrollment
References
Publications (1)
- DERIVEDHui D, Mahler DA, Larsson L, Wu J, Thomas S, Harrison CA, Hess K, Lopez-Mattei J, Thompson K, Gomez D, Jeter M, Lin S, Basen-Engquist K, Bruera E. High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial. Oncologist. 2021 Aug;26(8):e1470-e1479. doi: 10.1002/onco.13624. Epub 2020 Dec 14. PMID 33289280